Headline Date Published
Jefferies Global Healthcare Conference23-05-201717:00
Result of AGM17-05-201717:36
Block Listing Six Monthly Return10-05-201716:04
1st Quarter Results03-05-201712:00
Notice of Results19-04-201714:00
Holding(s) in Company07-04-201709:58
Additional RBP-6000 Clinical Study Results28-03-201714:00
Annual Financial Report23-03-201713:00
Top-line Phase 3 Trial Results - RBP-700013-03-201712:00
Director Resignation07-03-201717:29
Director/PDMR Shareholding27-02-201713:50
Director/PDMR Shareholding27-02-201713:22
Directorate Change22-02-201707:00
Full Year Financial Results22-02-201707:00
Director Declaration15-02-201717:04
Holding(s) in Company14-02-201716:19
Holding(s) in Company13-02-201707:00
Holding(s) in Company10-02-201716:48
Holding(s) in Company09-02-201709:56
Notice of Results06-02-201712:00
Director Declaration03-02-201713:30
Total Voting Rights01-02-201707:00
JP Morgan Healthcare Conference09-01-201713:00
Holding(s) in Company23-12-201609:21
Research & Development Day in New York09-12-201612:55
Additional Listing28-11-201613:53
Block Listing Six Monthly Return10-11-201615:54
3rd Quarter Results02-11-201612:00
Notice of Results27-10-201616:53
Directorate Change03-10-201614:00
Holding(s) in Company03-10-201609:17
State Attorneys General Complaint Filed27-09-201607:00
Civil Complaint Filed by State Attorneys General23-09-201607:00
Appointment Update01-09-201614:22
Top-line Phase 3 Pivotal Study Results - RBP-600017-08-201607:00
Director Declaration16-08-201614:19
Director/PDMR Shareholding12-08-201610:45
Director/PDMR Shareholding02-08-201615:05
Half Year Financial Results29-07-201607:00
Intention to List ADRs in U.S.15-07-201607:00
Notice of Results12-07-201614:00
Dividend Conversion Rate08-07-201616:30
Holding(s) in Company16-06-201610:23
Holding(s) in Company08-06-201617:10
Holding(s) in Company06-06-201612:19
Indivior welcomes Court ruling in ANDA litigation03-06-201616:23
Total Voting Rights01-06-201609:50
Buprenorphine Monthly Depot - FDA Fast Track26-05-201617:33
Director/PDMR Shareholding24-05-201615:45
Director/PDMR Shareholding16-05-201615:00
Director/PDMR Shareholding16-05-201613:45
Director/PDMR Shareholding12-05-201616:13
Result of AGM11-05-201617:50
Additional Listing04-05-201615:16
1st Quarter Results03-05-201612:00
Result of Phase 1 trial of RBP-630028-04-201614:25
Notice of Results20-04-201614:00
Holding(s) in Company15-04-201614:47
Annual Financial Report08-04-201613:23
Holding(s) in Company11-03-201615:25
Directorate Change11-03-201614:02
Director/PDMR Shareholding22-02-201615:41
Holding(s) in Company22-02-201610:22
Preliminary Full Year Results Announcement18-02-201607:00
Holding(s) in Company15-02-201610:00
Paragraph IV Notification11-02-201609:17
Holding(s) in Company09-02-201616:34
Notification of Full Year Results03-02-201607:00
Holding(s) in Company24-12-201509:44
Holding(s) in Company09-12-201516:29
R&D Day & Preliminary Financial Guidance 201609-12-201512:45
Repurchase of $75m debt07-12-201507:00
Holding(s) in Company02-12-201513:28
Director/PDMR Shareholding01-12-201514:03
Holding(s) in Company01-12-201508:43
FDA does not approve Naloxone Nasal Spray24-11-201516:55
Director/PDMR Shareholding04-11-201515:31
3rd Quarter Results03-11-201512:00
Director/PDMR Shareholding30-10-201515:08
Holding(s) in Company29-10-201508:42
Q3 Conference Call on Tuesday, November 3 201528-10-201509:41
Holding(s) in Company19-10-201514:07
Response to Court's decision on motion to amend12-10-201507:00
2015 Interim Dividend - Conversion Rate09-10-201512:00
Holding(s) in Company06-10-201510:05
Paragraph IV Notification05-10-201510:00
Director/PDMR Shareholding01-10-201509:54
Paragraph IV Notification25-09-201516:40
Director/PDMR Shareholding24-09-201509:56
Indivior PLC Research & Development Day Details08-09-201514:30
Holding(s) in Company08-09-201509:20
Holding(s) in Company28-08-201509:22
Holding(s) in Company28-08-201509:15
Holding(s) in Company28-08-201509:11
Holding(s) in Company05-08-201511:44
FDA Grants Naloxone Nasal Spray Priority Review29-07-201507:01
Half Yearly Financial Results29-07-201507:01
Holding(s) in Company27-07-201510:11
Holding(s) in Company24-07-201509:41
Notification of Half Year Results15-07-201513:00
Holding(s) in Company14-07-201509:08
Replacement Director/PDMR Shareholding03-07-201514:47
Director/PDMR Shareholding01-07-201511:28
Response to '832 Patent Case and will Appeal01-07-201508:56
New Trial Date for Patent Infringment Lawsuit01-07-201508:54
Director/PDMR Shareholding17-06-201516:06
Result of AGM14-05-201507:00
Director/PDMR Shareholding13-05-201512:20
Director/PDMR Shareholding13-05-201512:18
Director/PDMR Shareholding13-05-201512:18
Director/PDMR Shareholding13-05-201512:17
Director/PDMR Shareholding13-05-201512:14
Director/PDMR Shareholding13-05-201512:12
Director/PDMR Shareholding13-05-201512:12
Director/PDMR Shareholding13-05-201512:10
Director/PDMR Shareholding13-05-201512:09
Director/PDMR Shareholding13-05-201512:06
Chairman's Proxy Votes for AGM on 13 May 201512-05-201513:46
Outcome of Phase 3 Trial of RBP-700005-05-201512:00
1st Quarter Results05-05-201512:00
Holding(s) in Company27-04-201513:15
Notice of AGM10-04-201508:26
Holding(s) in Company31-03-201510:50
Director/PDMR Shareholding30-03-201516:21
Director/PDMR Shareholding30-03-201516:11
Director/PDMR Shareholding30-03-201507:00
Director/PDMR Shareholding27-03-201507:00
Director/PDMR Shareholding25-03-201507:00
Holding(s) in Company24-03-201514:35
Holding(s) in Company23-03-201514:38
Director/PDMR Shareholding23-03-201509:26
Director/PDMR Shareholding16-03-201507:00
Director/PDMR Shareholding05-03-201517:43
Holding(s) in Company04-03-201510:08
Director/PDMR Shareholding16-02-201518:11
Director/PDMR Shareholding16-02-201517:25
Director/PDMR Shareholding16-02-201507:00
Director/PDMR Shareholding12-02-201517:18
Director/PDMR Shareholding12-02-201507:00
Preliminary Full Year Results11-02-201507:00
Holding(s) in Company03-02-201516:50
Total Voting Rights02-02-201507:00
Holding(s) in Company29-01-201509:40
Holding(s) in Company26-01-201510:08
Reduction of Capital21-01-201512:45
Admission to the Official List and to Trading19-01-201512:54
Director/PDMR Shareholding13-01-201515:29
Holding(s) in Company12-01-201515:03
Holding(s) in Company08-01-201513:54
Holding(s) in Company07-01-201510:48
Director/PDMR Shareholding31-12-201413:18
Holding(s) in Company31-12-201411:02
Total Voting Rights31-12-201411:01
Director/PDMR Shareholding29-12-201414:48
Holding(s) in Company29-12-201410:22
Amended Director/PDMR Shareholding24-12-201408:56
Director/PDMR Shareholding24-12-201407:00
Second Price Monitoring Extn23-12-201416:40
Price Monitoring Extension23-12-201416:35
Admission to the Official List and to Trading23-12-201407:57